P51 / Research station
Compound research profile

BPC-157 Research: Experimental Models & Evidence Limits

An educational overview of BPC-157 tendon-model research, the questions those experiments address, and why laboratory findings require careful interpretation.

What research is discussed here?

BPC-157 is a synthetic pentadecapeptide. The cited 2003 study examined transected rat Achilles tendons and in vitro tendocyte growth. This is preclinical work in defined experimental models.

What did the researchers measure?

The paper reports tendon-healing and cell-growth observations within its experimental design. Its model and endpoints are central to interpreting the result; a broad claim about human recovery would answer a different question.

Where does interpretation stop?

An animal injury model and a cultured-cell experiment cannot by themselves establish human effectiveness or a clinical safety profile. This page summarizes that specific paper rather than treating it as a complete review of all BPC-157 literature.

What should a reader compare?

Look for controls, sample size, measurement methods, observation period and independent replication. Distinguish a change in a cell endpoint from a meaningful patient outcome, and check whether different studies used comparable materials.

Sources & further reading

  1. Staresinic et al., 2003 — rat tendon and in vitro study
This overview explains research context and evidence limits. It is not a systematic review or medical guidance. No availability, product quality, or equivalence to study materials is implied. Follow the original source for methods and limitations.

Continue reading

Explore all research guides →

Browse the compound directory →

P51 / Evidence tracker

FDA approval & clinical-trial status

Sources checked 2026-10-10 (UTC). Status describes registry records and named drug products.

FDA / United States

No FDA approval record located

The checked Drugs@FDA ingredient searches did not locate an approval record. This is a database search result, not an exhaustive regulatory determination; compounding eligibility is a separate question.

    FDA database and coverage ↗
    ClinicalTrials.gov

    Active study records reported

    1 active · 1 planned · 0 completed · 3 matching records

    Counts include matching drug or biological interventions in ClinicalTrials.gov. Biomarker-only studies and related compounds are excluded. Registration and a reported phase do not establish safety, efficacy, FDA approval, or that a trial is taking place as described. Check each record and its update date.

    Search the trial registry ↗
    View matching trial records (3)
    Publication archive

    Articles associated with BPC-157

    Indexed publications mentioning this compound in their title or abstract, newest first. Follow the original papers for findings and limitations; preprints are labeled.

    Open full source search ↗

    225 indexed matches. Sources checked 2026-10-10 (UTC).

    Search coverage is limited to Europe PMC. Related names, formulations, and study models may differ from listed research materials. A paper mentioning a compound is not necessarily a clinical trial or evidence of effectiveness.